It is indicated for the symptomatic treatment of mild to moderate osteoarthritis of the knee and hip:
Atrofort DUO belongs to a group of medicines called non-steroid antiinflammatory and antirheumatic medicines.
*Hungarian medicines database: ATC: M01AX, 2024. March (NNGYK – National Centre for Public Health and Pharmacy)
Osteoarthritis affects more than 600 million people globally, with more than 60 million people just in Western Europe.
It is a degenerative inflammatory disease associated with progressive damage to the articular cartilage, hollowing of the bones beneath the joint, the formation of irregular new bone tissue (osteophytes) on the articular cartilage, and these result in joint pain and stiffness. This pathological condition affects the weight-bearing joints, primarily the knees and hips.
One of the possible treatments for the symptoms of osteoarthritis are SYSADOAs (symptomatic slow-acting drugs for osteoarthritis), such as glucosamine and chondroitin sulfate, the active ingredients of Atrofort Duo.
Extensive clinical results show that after glucosamine sulphate and/or chondroitin sulphate therapy:
Over-the-counter medicine.
film-coated tablet
90 film-coated tablets
3×1 film-coated tablets per day for adults in a course-like dosage. The total duration of treatment is 3 months, which can be repeated several times a year, with 2-month breaks. It is not recommended for children and adolescents under 18 years of age.
NAME OF ACTIVE INGREDIENT | ACTIVE-INGREDIENT CONTENT IN 1 FILM_COATED TABLET |
Glucosamine sulphate | 500 mg |
Chondroitin sulphate sodium | 267 mg |